Managed care
Toxicity Assessors Global of Pennsylvania
Toxicity Assessors Global of Pennsylvania was paid $52K by Medicaid between Mar 2022 and Sep 2022, across 8 billing codes. Its largest line is 87636, Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B — 45% of everything it billed.
33Billing provider infoTOXICITY ASSESSORS GLOBAL OF PENNSYLVANIA
SANTA MONICA, CA 90401
SANTA MONICA, CA 90401
33aNPI1710508585assigned 05/02/2020
33bProvider typePoint of Service
28Total paid$52K
24GClaims3,202
24DCodes billed8
24AFirst – last monthMar 2022 – Sep 2022
Compared with peers
Next to other Point of Service providers in California
Rank by total paid#22 of 45
Median peer was paid$42K
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 3,202 | $52K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 45% | 237 | 67 | $23K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 26% | 396 | 148 | $13K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 15% | 744 | 252 | $8K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 10% | 1,112 | 304 | $5K |
| 99442 | 3.6% | 315 | 139 | $2K | |
| 99441 | <1% | 19 | 19 | $180.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 340 | 121 | $160.00 |
| 86701 | 0% | 39 | 38 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAGYEKUM, AUGUSTINE (MEDICAL DIRECTOR)